Dongkook Pharmaceutical announced on the 18th that it will exclusively sell 'NicoStop' and 'RheumaStop Powerplaster,' products from Samyang Holdings' Biofarm Group, in the domestic market. NicoStop is a patch that reduces withdrawal symptoms when quitting smoking. RheumaStop Powerplaster is a topical treatment for arthritis and muscle pain, packaged as a plaster pad.
NicoStop, launched in 1997, maintains a constant blood nicotine level for 24 hours, suppressing the desire to smoke. The product is used in smoking cessation education at public health centers. Dongkook Pharmaceutical will sell NicoStop and has gained entry into public health distribution.
RheumaStop Powerplaster is a non-steroidal anti-inflammatory pain reliever that is a renewal of the RheumaStop plaster launched in 1998. It contains the highest concentration (70 mg) of diclofenac among plaster products for the same area.
When Samyang Holdings supplies the products, Dongkook Pharmaceutical will sell them domestically. A Dongkook Pharmaceutical official noted, 'We will contribute to the health of our country in a super-aged society.'